Axsome Therapeutics, Inc. (AXSM) stock
AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/30
$134.00−1.95 (-1.43%)
Close on Nov 18, 2026Market cap $7.02BP/E –Yield –
Axsome Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Axsome Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -24.7%. For fiscal 2025 it was -28.7%, against -74.5% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -28.7% | +45.8 |
| FY2024 | Dec 31, 2024 | -74.5% | +13.9 |
| FY2023 | Dec 31, 2023 | -88.4% | +285.6 |
| FY2022 | Dec 31, 2022 | -374.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -23.5% | +8.5 |
| Q1 FY2026 | Mar 31, 2026 | -33.8% | +15.2 |
| Q4 FY2025 | Dec 31, 2025 | -14.6% | +48.5 |
| Q3 FY2025 | Sep 30, 2025 | -27.6% | +34.0 |
| Q2 FY2025 | Jun 30, 2025 | -32.0% | +59.1 |
| Q1 FY2025 | Mar 31, 2025 | -48.9% | +42.2 |
| Q4 FY2024 | Dec 31, 2024 | -63.1% | +74.8 |
| Q3 FY2024 | Sep 30, 2024 | -61.7% | +46.0 |
| Q2 FY2024 | Jun 30, 2024 | -91.0% | +52.8 |
| Q1 FY2024 | Mar 31, 2024 | -91.1% | −79.3 |
| Q4 FY2023 | Dec 31, 2023 | -137.9% | +113.4 |
| Q3 FY2023 | Sep 30, 2023 | -107.6% | +158.5 |
| Q2 FY2023 | Jun 30, 2023 | -143.8% | +326.0 |
| Q1 FY2023 | Mar 31, 2023 | -11.9% | – |
| Q4 FY2022 | Dec 31, 2022 | -251.3% | – |
| Q3 FY2022 | Sep 30, 2022 | -266.1% | – |
| Q2 FY2022 | Jun 30, 2022 | -469.8% | – |
See a number that looks wrong?